Skip to main content

Table 3 Association of genetically predicted PSC with risk of UC and CD

From: Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study

Exposure

Outcome

Method

SNPs

b

se

P value

OR (95% CI)

Primary sclerosing cholangitis

Ulcerative colitis

MR Egger

5

0.002156613

0.001954797

0.350475456

1.0022 (0.9983–1.0060)

Weighted median

5

0.00157667

0.00033714

2.91671E-06

1.0016 (1.0009–1.0022)

Inverse variance weighted

5

0.001395479

0.000285331

1.00457E-06

1.0014 (1.0008–1.0020)

Simple mode

5

0.001674616

0.000507346

0.029912705

1.0017 (1.0007–1.0027)

Weighted mode

5

0.001723726

0.000477383

0.022540952

1.0017 (1.0008–1.0027)

Primary sclerosing cholangitis

Crohn’s disease

MR Egger

17

-0.097709

0.06603742

0.15967422

0.9069 (0.7968–1.0322)

Weighted median

17

-0.0306259

0.04773732

0.52116485

0.9698 (0.8832–1.0650)

Inverse variance weighted

17

0.08913064

0.04867668

0.0670894

1.0932 (0.9937–1.2027)

Simple mode

17

-0.002681

0.12079877

0.98256754

0.9973 (0.7871–1.2638)

Weighted mode

17

-0.0388213

0.04548044

0.40593454

0.9619 (0.8799–1.0516)

  1. SNPs Single nucleotide polymorphisms, OR Odds ratio, CI Confidence interval